by Wim Mees | Aug 17, 2022 | Team events
Work hard, play hard!At myNEO we have afterwork drinks every month, this time we decided to enjoy the nice weather and have our well-deserved drinks at summer bar, Gazon. Some sun, refreshing drinks, and great colleagues made sure this was a fun and...by Wim Mees | Mar 1, 2022 | Team events
myNEO fully endorses a work hard/play hard balance and so we have at least once a month an afterwork drink or dinner. We think it is important to keep the team spirit alive to enable better interpersonal communication leading to more efficient team working...by Wim Mees | Aug 11, 2021 | Team events
This week we had a teambuilding activity with the myNEO team! We started the night with some serious action and jumped our way through the inflatable park of Jumpsky in Ghent. After that, we enjoyed a super tasty meal in the city centre of Ghent and we finished...by Wim Mees | Jun 10, 2021 | Team events
Due to corona, the myNEO team had to work fully remotely in the last months. As the regulations are finally becoming less strict, we decided to organize a small team event outside. We had some drinks accompanied with appetizers in the afternoon, followed by some...by Wim Mees | Oct 21, 2020 | Team events
This week the myNEO team had multiple reasons to celebrate! Bruno his promotion to CTO 1 year working anniversary of Lore and Lien End of the internship of Claudia 500+ followers on LinkedIn We had a great night over drinks and some...by Wim Mees | Jun 10, 2020 | Team events
Yesterday myNEO organised its first teambuilding activity after the lockdown. We all worked remotely during the lockdown so it was nice to all be together again as a team. We had some drinks, ate a tasty diner and played some board games to finish off the...The process starts with the collection of both patient blood and a tumor biopsy.
Whole-Genome Sequencing data from matched tumor and normal DNA is required for each patient.
Following alignment of these reads to the genome, somatic gene alterations in the tumor genome are detected using a collection of algorithms called 'neoX'.
Next, these somatic gene alterations are translated in-silico to obtain the tumor-specific peptides
In a last step, the peptides are prioritized using an immunogenicity predictor (neoIM) and two presentation predictors (neoMS and MHCrank).